Sirnaomics-B (02257.HK) Chairman Dr. Patrick Lu Acquires 20,300 Shares, Stake Rises to 16.12%

NewTimeSpace · 2026/06/24 21:49 · By Boyuan Chen

Sirnaomics (2257.HK) announced that its executive director and chairman Dr. Patrick Lu purchased an aggregate of 20,300 ordinary shares on the open market on June 24, 2026, at an average price of approximately HK$5.00 per share using personal funds, bringing his total interest to 17,685,996 shares, representing 16.12% of total issued share capital. Dr. Lu expressed full confidence in the Group's development prospects and potential growth, and does not rule out further increasing his shareholding at an appropriate time subject to applicable laws and regulations.

Sirnaomics Ltd. (2257.HK) announced on June 24, 2026, that the Board was informed by Dr. Patrick Lu, the Company's executive director and chairman, that Dr. Lu purchased an aggregate of 20,300 ordinary shares of the Company on the open market on June 24, 2026, using his personal funds at an average price of approximately HK$5.00 per share. Immediately following the purchase, Dr. Lu is interested in an aggregate of 17,685,996 shares, representing 16.12% of the total issued share capital of the Company as of the date of this announcement.

As informed by Dr. Lu, he is fully confident in the overall development prospects and potential growth of the Group. Subject to compliance with applicable laws and regulatory requirements, Dr. Lu does not rule out the possibility of further increasing his shareholding in the Company at an appropriate time.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

SIRNAOMICS-B 02257.HK Acquires